Therapeutic approach | Before CT | After CT | Improvement | p |
---|---|---|---|---|
Percutaneous revascularisation, n (%) | 0 | 6 (7.1%) | 6 (7.1%) | _____ |
Medical therapy, n (%) | 22 (25.9%) | _____ | ||
Antiplatelets | 31 (36.1%) | 42 (49.4%) | +12.9% | ns |
Statins | 45 (52.9%) | 58 (68.2%) | +15.3% | 0.041 |
ACE inhibitor/ARB | 69 (81.2%) | 73 (85.9%) | +4.7% | ns |
Oral hypoglycaemic agents | 73 (85.9%) | 74 (87.1%) | +1.2% | ns |
Insulin therapy | 42 (49.4%) | 43 (50.6%) | +1.2% | ns |